保龄宝: 关于变更公司经营范围及修订《公司章程》的公告

Core Viewpoint - The company, Baolingbao Biological Co., Ltd., has proposed changes to its business scope and amendments to its articles of association to meet operational development needs [1][2]. Business Scope Changes - The business scope has been expanded to include the production and sales of pharmaceuticals, as well as the import and export of drugs, which were not included in the previous scope [1][2]. - The previous business scope included starch sugar, other foods, food additives, health foods, medicinal auxiliary materials, feed additives, beverage research and development, production, and sales, as well as pre-packaged food wholesale and grain purchase and sales [1][2]. Amendments to Articles of Association - The amendments to the articles of association reflect the changes in the business scope, ensuring compliance with relevant laws and regulations [3][4]. - The board of directors has outlined the approval authority for significant transactions, including asset purchases or sales, external investments, and guarantees, which must be approved by the board [5][6]. Approval Process - The proposed changes will be submitted to the shareholders' meeting for approval, and the management team will be authorized to handle the necessary business registration changes [7][8]. - The company emphasizes that all amendments will be subject to the final approval of the relevant regulatory authorities [9].